Last Name


Search Results to Roumen Balabanov

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Balabanov, Roumen

Item TypeName
Concept Multiple Sclerosis, Relapsing-Remitting
Concept Multiple Sclerosis
Academic Article Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Academic Article Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.
Academic Article IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination.
Academic Article Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
Academic Article Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Academic Article Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis.
Academic Article Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Academic Article Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Academic Article Treatment of natalizumab-associated PML with filgrastim.
Academic Article Outcomes of natalizumab treatment within 3?years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.
Academic Article IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rß1 internalization and suppress EAE.
Academic Article Pre-clinical and Clinical Implications of "Inside-Out" vs. "Outside-In" Paradigms in Multiple Sclerosis Etiopathogenesis.
Academic Article Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
Academic Article Correction to: Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study.
Academic Article ZEB1 promotes pathogenic Th1 and Th17 cell differentiation in multiple sclerosis.
Academic Article Repurposing the cardiac glycoside digoxin to stimulate myelin regeneration in chemically-induced and immune-mediated mouse models of multiple sclerosis.

Search Criteria
  • Sclerosis